Oncotelic Therapeutics (OTLC) Short-Term Debt issuances (2021 - 2026)
Oncotelic Therapeutics (OTLC) recorded Short-Term Debt issuances of $462,874 in Q4 2025, compared with $41,000 a year earlier and up 208.6% from the prior quarter.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Short-Term Debt issuances (2021 - 2026) Analysis & Trends
For FY2025, Oncotelic Therapeutics reported Short-Term Debt issuances of $907,874, up 38.4% from FY2024.
- Annual Short-Term Debt issuances has a five-year compound annual growth rate of 64.7% (FY2020 to FY2025).
- Across earlier years, Short-Term Debt issuances came in at $656,000 in FY2024 (-53.5%), $1.41 million in FY2023 and $350,050 in FY2021 (+366.7%).
- The Q4 2025 figure is the highest quarterly Short-Term Debt issuances since Q2 2023.
- On a year-over-year basis, Short-Term Debt issuances rose in 1 of the last seven quarters, with an average decline of 36.3%.
- Per Business Quant, the preceding three quarters came in at $150,000 (Q3 2025), $135,000 (Q2 2025) and $160,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 2.28 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | 40,922.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40,922.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 462,874.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 420,000.00 |
| Jun 30, 2023 | 490,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2021 | -670,825.00 |
| Sep 30, 2021 | 276,000.00 |
| Jun 30, 2021 | 624,875.00 |
| Mar 31, 2021 | 120,000.00 |
API Access
Oncotelic Therapeutics Short-Term Debt issuances API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt-issuances", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();